AI in Scientific Publications

The Role of AI in Transforming Scientific Publications

Scientific publishing is evolving rapidly with the advent of AI, transforming content creation, data visualization, and workflow management. While pharma publications demand rigorous accuracy and compliance, AI is making the journey from data to publication faster and more efficient and accelerating processes without compromising quality. However, it is vital to recognize at the outset that…...
Read More

Top Stories

NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers )?

The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Artificial Intelligence and Writing

Breaking Barriers: Exploring the Power of AI and NLP in Scientific Communication

Learn how medical publication professionals and medical affairs teams can embrace AI and NLP tools...
HEOR Pharma Payers

Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements

HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...

Medical Information in the Digital Age – Quick and Efficient Meets Responsive and Responsible

Medical Information (MI teams across the pharmaceutical industry respond to product-related medical queries from HCPs...

From Transactional to Transformational: Bringing Patient Centricity to the Next Level

The pharma industry’s focus is shifting from the transactional approach to a transformational approach by...

Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences

The growth and adoption of the internet and mobile technology have provided publishers and authors...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.